Skip to main content

Advertisement

SpringerLink
Log in

Co-expression of AQP3 and AQP5 in esophageal squamous cell carcinoma correlates with aggressive tumor progression and poor prognosis

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

To investigate the expression patterns of aquaporin 3 (AQP) 3 and AQP5, to evaluate their relationships with clinicopathological characteristics, and to determine their correlations with survival in esophageal squamous cell carcinoma (ESCC) patients, expression levels of AQP3 and AQP5 proteins in 126 ESCC patients were detected by immunohistochemistry. Then, paired Student’s t-test, chi-square test, Spearman’s rank correlation, Kaplan–Meier plots, and Cox proportional hazards regression model were used to analyze their associations with clinicopathological characteristics and survivals of ESCC patients. Both AQP3 and AQP5 proteins were localized on the cell membrane of tumor cells in ESCC tissues. The expression levels of two proteins in ESCC tissues were significantly higher than those in adjacent normal tissues (both P < 0.001). Additionally, high expression of AQP3 and AQP5 was both correlated with advanced invasion depth (both P = 0.01), aggressive lymph node status (P = 0.02 and 0.01, respectively), and positive distant metastasis (both P = 0.01). However, the overexpression of AQP3 and AQP5 alone did not influence the prognosis. Furthermore, ESCC patients with the co-expression of AQP3 and AQP5 showed the poorest prognosis in overall (P = 0.002) and disease-free survival (P < 0.001). Multivariate analysis showed that the co-expression of AQP3 and AQP5 was an independent prognostic factors of overall (P = 0.01) and disease-free survival (P = 0.01) in ESCC. Our data demonstrate for the first time that high expression of both AQP3 and AQP5, not each alone, is an independent poor prognostic factor in ESCC patients. Combined detection of the two proteins’ expression may help to predict the progression and the prognosis of ESCC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Feng JF, Huang Y, Zhao Q. Tumor length in elderly patients with esophageal squamous cell carcinoma: is it a prognostic factor? Ups J Med Sci. 2013 (in press).

  2. Shigaki H, Baba Y, Watanabe M, Murata A, Ishimoto T, Iwatsuki M, Iwagami S, Nosho K, Baba H. PIK3CA mutation is associated with a favorable prognosis among patients with curatively resected esophageal squamous cell carcinoma. Clin Cancer Res. 2013;19:2451–9.

    Article  PubMed  CAS  Google Scholar 

  3. Wang JH, Chen XT, Wen ZS, Zheng M, Deng JM, Wang MZ, Lin HX, Chen K, Li J, Yun JP, Luo RZ, Song LB. High expression of GOLPH3 in esophageal squamous cell carcinoma correlates with poor prognosis. PLoS ONE. 2012;7:e45622.

    Article  PubMed  CAS  Google Scholar 

  4. Jemal A, Bray F, Center MM, Ferlay J, Ward E. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  5. Chuangui C, Peng T, Zhentao Y. The expression of high mobility group box 1 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Pathol Oncol Res. 2012;18:1021–7.

    Article  PubMed  Google Scholar 

  6. Xie JJ, Xu LY, Wu ZY, Li LY, Xu XE, Wu JY, Huang Q, Li EM. Expression of cysteine-rich 61 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma. Eur J Surg Oncol. 2011;37:669–74.

    Article  PubMed  CAS  Google Scholar 

  7. Huber VJ, Tsujita M, Nakada T. Aquaporins in drug discovery and pharmacotherapy. Mol Aspects Med. 2012;33:691–703.

    Article  PubMed  CAS  Google Scholar 

  8. Verkman AS. Aquaporins in clinical medicine. Annu Rev Med. 2012;63:303–16.

    Article  PubMed  CAS  Google Scholar 

  9. Verkman AS. Aquaporins at a glance. J Cell Sci. 2011;124:2107–12.

    Article  PubMed  CAS  Google Scholar 

  10. Marinelli RA, Lehmann GL, Soria LR, Marchissio MJ. Hepatocyte aquaporins in bile formation and cholestasis. Front Biosci. 2011;16:2642–52.

    Article  CAS  Google Scholar 

  11. Hachez C, Chaumont F. Aquaporins: a family of highly regulated multifunctional channels. Adv Exp Med Biol. 2010;679:1–17.

    Article  PubMed  CAS  Google Scholar 

  12. Lee JY, Shin JH, Song KH, Lim JS, Sul CK. Expression of aquaporin-3 in ipsilateral rat kidney with unilateral partial ureteral obstruction. Korean J Urol. 2013;54:266–70.

    Article  PubMed  Google Scholar 

  13. Nong YQ, Liu FH, Chen Y, Wang F. The expression and distribution of aquaporin 3 in mouse embryos before and after vitrification. J Assist Reprod Genet. 2013;30:601–6.

    Google Scholar 

  14. Niu D, Kondo T, Nakazawa T, Yamane T, Mochizuki K, Kawasaki T, Matsuzaki T, Takata K, Katoh R. Expression of aquaporin3 in human neoplastic tissues. Histopathology. 2012;61:543–51.

    PubMed  Google Scholar 

  15. Zhang Z, Chen Z, Song Y, Zhang P, Hu J, Bai C. Expression of aquaporin 5 increases proliferation and metastasis potential of lung cancer. J Pathol. 2010;221:210–20.

    Article  PubMed  CAS  Google Scholar 

  16. Huang Y, Zhu Z, Sun M, Wang J, Guo R, Shen L, Wu W. Critical role of aquaporin-3 in the human epidermal growth factor-induced migration and proliferation in the human gastric adenocarcinoma cells. Cancer Biol Ther. 2010;9:1000–7.

    Article  PubMed  CAS  Google Scholar 

  17. Shen L, Zhu Z, Huang Y, Shu Y, Sun M, Xu H, Zhang G, Guo R, Wei W, Wu W. Expression profile of multiple aquaporins in human gastric carcinoma and its clinical significance. Biomed Pharmacother. 2010;64:313–8.

    Article  PubMed  CAS  Google Scholar 

  18. Ismail M, Bokaee S, Morgan R, Davies J, Harrington KJ, Pandha H. Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy. Br J Cancer. 2009;100:1889–95.

    Article  PubMed  CAS  Google Scholar 

  19. Janosi L, Ceccarelli M. The gating mechanism of the human aquaporin 5 revealed by molecular dynamics simulations. PLoS ONE. 2013;8:e59897.

    Article  PubMed  CAS  Google Scholar 

  20. Kawedia JD, Yang F, Sartor MA, Gozal D, Czyzyk-Krzeska M, Menon AG. Hypoxia and hypoxia mimetics decrease aquaporin 5 (AQP5) expression through both hypoxia inducible factor-1α and proteasome-mediated pathways. PLoS ONE. 2013;8:e57541.

    Article  PubMed  CAS  Google Scholar 

  21. Matsuzaki T, Susa T, Shimizu K, Sawai N, Suzuki T, Aoki T, Yokoo S, Takata K. Function of the membrane water channel aquaporin-5 in the salivary gland. Acta Histochem Cytochem. 2012;45:251–9.

    Article  PubMed  CAS  Google Scholar 

  22. Zhang Z, Chen Z, Song Y, Zhang P, Hu J, Bai C. Expression of aquaporin 5 increases proliferation and metastasis potential of lung cancer. J Pathol. 2010;221:210–20.

    Article  PubMed  CAS  Google Scholar 

  23. Kang SK, Chae YK, Woo J, Kim MS, Park JC, Lee J, Soria JC, Jang SJ, Sidransky D, Moon C. Role of human aquaporin 5 in colorectal carcinogenesis. Am J Pathol. 2008;173:518–25.

    Article  PubMed  CAS  Google Scholar 

  24. Watanabe T, Fujii T, Oya T, Horikawa N, Tabuchi Y, Takahashi Y, Morii M, Takeguchi N, Tsukada K, Sakai H. Involvement of aquaporin-5 in differentiation of human gastric cancer cells. J Physiol Sci. 2009;59:113–22.

    Article  PubMed  CAS  Google Scholar 

  25. Kusayama M, Wada K, Nagata M, Ishimoto S, Takahashi H, Yoneda M, Nakajima A, Okura M, Kogo M, Kamisaki Y. Critical role of aquaporin 3 on growth of human esophageal and oral squamous cell carcinoma. Cancer Sci. 2011;102:1128–36.

    Article  PubMed  CAS  Google Scholar 

  26. Ishimoto S, Wada K, Usami Y, Tanaka N, Aikawa T, Okura M, Nakajima A, Kogo M, Kamisaki Y. Differential expression of aquaporin 5 and aquaporin 3 in squamous cell carcinoma and adenoid cystic carcinoma. Int J Oncol. 2012;41:67–75.

    PubMed  CAS  Google Scholar 

  27. Zhang T, Zhao C, Chen D, Zhou Z. Overexpression of AQP5 in cervical cancer: correlation with clinicopathological features and prognosis. Med Oncol. 2012;29:1998–2004.

    Article  PubMed  CAS  Google Scholar 

  28. Woo J, Lee J, Chae YK, Kim MS, Baek JH, Park JC, Park MJ, Smith IM, Trink B, Ratovitski E, Lee T, Park B, Jang SJ, Soria JC, Califano JA, Sidransky D, Moon C. Overexpression of AQP5, a putative oncogene, promotes cell growth and transformation. Cancer Lett. 2008;264:54–62.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Intervention, The First Affiliated Hospital of Shantou University, Fujian, 515031, China

    Sulin Liu

  2. Department of Pharmacy, Shantou University Medical College Affiliated Tumor Hospital, Fujian, 515031, China

    Shuyao Zhang

  3. Department of CT, Shantou University Medical College Affiliated Tumor Hospital, Fujian, 515031, China

    Hong Jiang

  4. Department of Integrative Medicine, Shantou University Medical College Affiliated Tumor Hospital, Fujian, 515031, China

    Yuxian Yang & Yi Jiang

Authors
  1. Sulin Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shuyao Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hong Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuxian Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yi Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yi Jiang.

Additional information

Sulin Liu and Shuyao Zhang contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, S., Zhang, S., Jiang, H. et al. Co-expression of AQP3 and AQP5 in esophageal squamous cell carcinoma correlates with aggressive tumor progression and poor prognosis. Med Oncol 30, 636 (2013). https://doi.org/10.1007/s12032-013-0636-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-013-0636-2

Keywords

Search

Navigation